Shopping Cart
- Remove All
- Your shopping cart is currently empty
Cevimeline, a parasympathomimetic and muscarinic agonist, affects M1 and M3 receptors. Cevimeline has been shown to treat dry mouth and Sj gren's syndrome. It is also used to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer survivors after radiotherapy.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,158 | 7-10 days |
Description | Cevimeline, a parasympathomimetic and muscarinic agonist, affects M1 and M3 receptors. Cevimeline has been shown to treat dry mouth and Sj gren's syndrome. It is also used to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer survivors after radiotherapy. |
Alias | SNI 2011, HSDB 7286, FKS 508, AF-102B |
Molecular Weight | 199.31 |
Formula | C10H17NOS |
Cas No. | 107233-08-9 |
Relative Density. | 1.19 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.